![Robert Hurwitz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Robert Hurwitz is the founder of The Coral Co. which was founded in 1987.
He is currently the Chairman of BioMendics LLC and a Trustee at The MetroHealth System, Inc. where he started in 2017.
He was previously an Advisor at Edgewater Capital Partners.
Postes actifs de Robert Hurwitz
| Sociétés | Poste | Début |
|---|---|---|
The Coral Co.
 The Coral Co. Real Estate DevelopmentFinance Operates as a commercial and residential real estate developer | Fondateur | 01/01/1987 |
The MetroHealth System, Inc.
 The MetroHealth System, Inc. Hospital/Nursing ManagementHealth Services Provides health care services | Directeur/Membre du Conseil | 01/01/2017 |
BioMendics LLC
 BioMendics LLC BiotechnologyHealth Technology Provides research and treatment of acute wounds, burns & inflammatory skin conditions | Président | - |
Anciens postes connus de Robert Hurwitz
| Sociétés | Poste | Fin |
|---|---|---|
Edgewater Capital Partners
 Edgewater Capital Partners Investment ManagersFinance Edgewater Capital Partners invests in lower middle market companies located in the Unites States with an EBITDA of less than USD 25 million and revenues of less than USD 100 million. The firm focuses on specialty industrials, life science, advanced materials and specialty chemicals. It participates in MBO transactions with an investment size of up to USD 50 million. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
13
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Edgewater Capital Partners
Edgewater Capital Partners Investment ManagersFinance Edgewater Capital Partners invests in lower middle market companies located in the Unites States with an EBITDA of less than USD 25 million and revenues of less than USD 100 million. The firm focuses on specialty industrials, life science, advanced materials and specialty chemicals. It participates in MBO transactions with an investment size of up to USD 50 million. | Finance |
The MetroHealth System, Inc.
The MetroHealth System, Inc. Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
The Coral Co.
The Coral Co. Real Estate DevelopmentFinance Operates as a commercial and residential real estate developer | Finance |
BioMendics LLC
BioMendics LLC BiotechnologyHealth Technology Provides research and treatment of acute wounds, burns & inflammatory skin conditions | Health Technology |
Choisissez Zonebourse 
